Literature DB >> 24175048

Nephrectomy for a renal metastasis of undiagnosed hepatocellular carcinoma arising from an orthotopic liver transplant undertaken for cryptogenic cirrhosis.

Kevin W K Ong1, Binoy Joseph, Dennis V Gyomber, Damien M Bolton, Nathan Lawrentschuk.   

Abstract

Urological involvement of hepatocellular carcinoma (HCC) is rare; HCC arising in an orthotopic liver transplant (OLT) is exceptionally rare. Here we report the case of a 70-year-old man who was incidentally found to have metastatic HCC in the right kidney arising from his OLT undertaken for cryptogenic cirrhosis 10 years previously. Adding to the complexity of this case was the lack of an obvious liver primary HCC at the time of the radical nephrectomy, thus making the final diagnosis all but impossible. We believe this report represents the first report of HCC metastasizing to the kidney after OLT and adds to the few reports in the literature of HCC arising in transplanted livers.

Entities:  

Keywords:  Kidney neoplasms; Liver neoplasms; Liver transplantation; Neoplasm metastasis; Nephrectomy

Year:  2013        PMID: 24175048      PMCID: PMC3806998          DOI: 10.4111/kju.2013.54.10.715

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  9 in total

1.  Secondary carcinomas of the kidney.

Authors:  D G Wagle; R H Moore; G P Murphy
Journal:  J Urol       Date:  1975-07       Impact factor: 7.450

2.  De novo hepatocellular carcinoma in a hepatic allograft with recurrent hepatitis C cirrhosis.

Authors:  R Saxena; M Q Ye; S Emre; F Klion; M A Nalesnik; S N Thung
Journal:  Liver Transpl Surg       Date:  1999-01

Review 3.  Liver transplantation and hepatocellular carcinoma.

Authors:  I Yokoyama; H Takagi
Journal:  Semin Surg Oncol       Date:  1996 May-Jun

4.  De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.

Authors:  S Jonas; N Rayes; U Neumann; R Neuhaus; W O Bechstein; O Guckelberger; S G Tullius; S Serke; P Neuhaus
Journal:  Cancer       Date:  1997-09-15       Impact factor: 6.860

5.  Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation.

Authors:  Sanjiv Saigal; Suzanne Norris; Paolo Muiesan; Mohamed Rela; Nigel Heaton; John O'Grady
Journal:  Liver Transpl       Date:  2002-05       Impact factor: 5.799

Review 6.  Management of hepatocellular carcinoma.

Authors:  Janice N Cormier; K Tyson Thomas; Ravi S Chari; C Wright Pinson
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

7.  Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.

Authors:  Christopher J Hoffmann; Aruna K Subramanian; Andrew M Cameron; Eric A Engels
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

8.  Donor origin of de novo hepatocellular carcinoma in hepatic allografts.

Authors:  Peer Flemming; Hans L Tillmann; Hannelore Barg-Hock; Wolfram Kleeberger; Michael P Manns; Juergen Klempnauer; Hans H Kreipe
Journal:  Transplantation       Date:  2003-09-15       Impact factor: 4.939

Review 9.  Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy.

Authors:  Alessandro Volpe; John R Kachura; William R Geddie; Andrew J Evans; Arash Gharajeh; Arthy Saravanan; Michael A S Jewett
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

  9 in total
  1 in total

1.  Renal metastasis from primary hepatocellular carcinoma: a case report.

Authors:  Ryoken Yamanaka; Yohei Sekino; Takashi Babasaki; Hiroyuki Kitano; Kenichiro Ikeda; Keisuke Goto; Keisuke Hieda; Shogo Inoue; Tetsutaro Hayashi; Jun Teishima; Hiroshi Aikata; Kazuaki Chayama; Kazuhiro Sentani; Wataru Yasui; Akio Matsubara
Journal:  Int Cancer Conf J       Date:  2020-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.